Early modulation by the dopamine D4 receptor of morphine-induced changes in the opioid peptide systems in the rat caudate putamen

Journal of Neuroscience Research

Volumn 91, Issue 12, 2013, Pages 1533-1540

  Gago, Belén ^a,c   Fuxe, Kjell ^b   Brené, Stefan ^b   Díaz Cabiale, Zaida ^a   Reina Sánchez, María Dolores ^a   Suárez Boomgaard, Diana ^a   Roales Buján, Ruth ^a   Valderrama Carvajal, Alejandra ^a   de la Calle, Adelaida ^a   Rivera, Alicia ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

D4 opioid receptors interactions; Opioid peptides; Striatum; Transcription factors

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 4 RECEPTOR; DYNORPHIN; ENKEPHALIN; MESSENGER RNA; MORPHINE; MU OPIATE RECEPTOR; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PUTAMEN; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; STRIATE CORTEX;

D4/Μ OPIOID RECEPTORS INTERACTIONS; OPIOID PEPTIDES; STRIATUM; TRANSCRIPTION FACTORS;

ANALGESICS, OPIOID; ANIMALS; DYNORPHINS; ENKEPHALINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MORPHINE; OPIOID PEPTIDES; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D4; RECEPTORS, OPIOID, MU; RNA, MESSENGER;

EID: 84886640675     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23277     Document Type: Article

References (69)

1. Agnati LF, Ferré S, Lluis C, Franco R, Fuxe K. 2003. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 55:509-550.
2. Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, Von Zastrow M, Grandy DK, Williams JT. 2002. Mu-opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 22:5769-5776.
3. Angulo JA, McEwen BS. 1994. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Rev 19:1-28.
4. Bacher B, Wang X, Schulz S, Höllt V. 1996. Induction of proenkephalin gene expression in cultured bovine chromaffin cells is dependent on protein synthesis of AP-1 proteins. J Neurochem 66:2264-2271.
5. Bilecki W, Wawrzczak-Bargiela A, Przewlocki R. 2004. Activation of AP-1 and CRE-dependent gene expression via mu-opioid receptor. J Neurochem 90:874-882.
6. Bontempi B, Sharp FR. 1997. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area. J Neurosci 17:8596-8612.
7. Börner C, Höllt V, Kraus J. 2002. Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene. Mol Pharmacol 61:800-805.
8. Bronstein DM, Ye H, Pennypacker KR, Hudson PM, Hong JS. 1994. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat. Brain Res Mol Brain Res 23:191-203.
9. Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ. 1998. Regulation of cocaine reward by CREB. Science 282:2272-2275.
10. Chang SL, Squinto SP, Harlan RE. 1988. Morphine activation of c-fos expression in rat brain. Biochem Biophys Res Commun 157:698-704.
11. Cole RL, Konradi C, Douglass J, Hyman SE. 1995. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14:813-823.
12. Collins-Hicok J, Lin L, Spiro C, Laybourn PJ, Tschumper R, Rapacz B, McMurray CT. 1994. Induction of the rat prodynorphin gene through Gs-coupled receptors may involve phosphorylation-dependent derepression and activation. Mol Cell Biol 14:2837-2848.
13. Daunais JB, McGinty JF. 1994. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse 18:35-45.
14. Di Chiara G, Imperato A. 1988. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080.
15. Douglass J, McMurray CT, Garrett JE, Adelman JP, Calavetta L. 1989. Characterization of the rat prodynorphin gene. Mol Endocrinol 3:2070-2078.
16. Douglass J, McKinzie AA, Pollock KM. 1994. Identification of multiple DNA elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene. Mol Endocrinol 8:333-344.
17. Enrico P, Esposito G, Mura MA, Migheli R, Serra PA, Desole MS, Miele E, De Natale G, Miele M. 1997. Effects of allopurinol on striatal dopamine, ascorbate and uric acid during an acute morphine challenge: ex vivo and in vivo studies. Pharmacol Res 35:577-585.
18. Fuxe K, Marcellino D, Rivera A, Diaz-Cabiale Z, Filip M, Gago B, Roberts DC, Langel U, Genedani S, Ferraro L, de la Calle A, Narvaez J, Tanganelli S, Woods A, Agnati LF. 2008. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev 58:415-452.
19. Gago B, Fuxe K, Agnati L, Penafiel A, De La Calle A, Rivera A. 2007. Dopamine D4 receptor activation decreases the expression of mu-opioid receptors in the rat striatum. J Comp Neurol 502:358-366.
20. Gago B, Suárez-Boomgaard D, Fuxe K, Brené S, Reina-Sánchez MD, Rodríguez-Pérez LM, Agnati LF, de la Calle A. 2011. Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation. Brain Res 1407:47-61.
21. Garcia MM, Brown HE, Harlan RE. 1995. Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection. Brain Res 692:23-40.
22. Garcia MM, Anderson AT, Edwards R, Harlan RE. 2003. Morphine induction of c-fos expression in the rat forebrain through glutamatergic mechanisms: role of non-N-methyl-D-aspartate receptors. Neuroscience 119:787-794.
23. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O'Dowd BF. 2000. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 275:26128-26135.
24. Gerfen CR. 1992. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 15:285-320.
25. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR. 1990. D1 and D2 dopamine receptor regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432.
26. Gerfen CR, McGinty JF, Young WSD. 1991. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11:1016-1031.
27. Glase SA, Akunne HC, Georgic LM, Heffner TG, MacKenzie RG, Manley PJ, Pugsley TA, Wise LD. 1997. Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonists. J Med Chem 40:1771-1772.
28. Grande C, Zhu H, Martin AB, Lee M, Ortiz O, Hiroi N, Moratalla R. 2004. Chronic treatment with atypical neuroleptics induces striosomal FosB/DeltaFosB expression in rats. Biol Psychiatry 55:457-463.
29. Gutstein HB, Thome JL, Fine JL, Watson SJ, Akil H. 1998. Pattern of c-fos mRNA induction in rat brain by acute morphine. Can J Physiol Pharmacol 76:294-303.
30. Guttenberg ND, Klop H, Minami M, Satoh M, Voorn P. 1996. Co-localization of mu opioid receptor is greater with dynorphin than enkephalin in rat striatum. Neuroreport 7:2119-2124.
31. Hutchinson MR, Bland ST, Johnson KW, Rice KC, Maier SF, Watkins LR. 2007. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. Sci World J 7:98-111.
32. Jabourian M, Venance L, Bourgoin S, Ozon S, Pérez S, Godeheu G, Glowinski J, Kemel ML. 2005. Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation. Eur J Neurosci 21:3301-3309.
33. Johnson SW, North RA. 1992. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488.
34. Kobierski LA, Wong AE, Srivastava S, Borsook D, Hyman SE. 1999. Cyclic AMP-dependent activation of the proenkephalin gene requires phosphorylation of CREB at serine-133 and a Src-related kinase. J Neurochem 73:129-138.
35. Konradi C, Kobierski LA, Nguyen TV, Heckers S, Hyman SE. 1993. The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Proc Natl Acad Sci U S A 90:7005-7009.
36. Koob GF, Le Moal M. 2001. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129.
37. Lee PW, Lee YM. 2003. Transcriptional regulation of mu opioid receptor gene by cAMP pathway. Mol Pharmacol 64:1410-1418.
38. Liu J, Nickolenko J, Sharp FR. 1994. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 91:8537-8541.
39. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ. 1994. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350:412-438.
40. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL. 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383:819-823.
41. Matthews RT, German DC. 1984. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 11:617-625.
42. Mavridis M, Besson MJ. 1999. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression. Neuroscience 92:945-966.
43. Moratalla R, Xu M, Tonegawa S, Graybiel AM. 1996. Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc Natl Acad Sci U S A 93:14928-14933.
44. Muller DL, Unterwald EM. 2005. D1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration. J Pharmacol Exp Ther 314:148-154.
45. Petraschka M, Li S, Gilbert TL, Westenbroek RE, Bruchas MR, Schreiber S, Lowe J, Low MJ, Pintar JE, Chavkin C. 2007. The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation. Neuroscience 146:1795-1807.
46. Porras G, Di Matteo V, Fracasso C, Lucas G, De Deurwaerdère P, Caccia S, Esposito E, Spampinato U. 2002. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26:311-324.
47. Przewlocka B, Turchan J, Lason W, Przewlocki R. 1996. The effect of single and repeated morphine administration on the prodynorphin system activity in the nucleus accumbens and striatum of the rat. Neuroscience 70:749-754.
48. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T. 1994. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45:330-334.
49. Rivera A, Trias S, Peñafiel A, Narvaez JA, Diaz-Cabiale Z, Moratalla R, de la Calle A. 2003. Expression of D4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatum. Brain Res 989:35-41.
50. Rivera A, Peñafiel A, Megías M, Agnati LF, López-Téllez JF, Gago B, Gutiérrez A, de la Calle A, Fuxe K. 2008. Cellular localization and distribution of dopamine D4 receptors in the rat cerebral cortex and their relationship with the cortical dopaminergic and noradrenergic nerve terminal networks. Neuroscience 155:997-1010.
51. Rozenfeld R, Abul-Husn NS, Gomez I, Devi LA. 2007. An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function. Sci World J 7:64-73.
52. Sakai N, Thome J, Newton SS, Chen J, Kelz MB, Steffen C, Nestler EJ, Duman RS. 2002. Inducible and brain region-specific CREB transgenic mice. Mol Pharmacol 61:1453-1464.
53. Smith AP, Lee NM. 1988. Pharmacology of dynorphin. Annu Rev Pharmacol Toxicol 28:123-140.
54. Song P, Zhao ZQ. 2001. The involvement of glial cells in the development of morphine tolerance. Neurosci Res 39:281-286.
55. Steiner H, Gerfen CR. 1999. Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons. Neuroscience 88:795-810.
56. Stiene-Martin A, Knapp PE, Martin K, Gurwell JA, Ryan S, Thornton SR, Smith FL, Hauser KF. 2001. Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo. Glia 36:78-88.
57. Svenningsson P, Ström A, Johansson B, Fredholm BB. 1995. Increased expression of c-jun, junB, AP-1, and preproenkephalin mRNA in rat striatum following a single injection of caffeine. J Neurosci 15:3583-3593.
58. Taracha E, Lehner M, Wislowska-Stanek A, Zienowicz M, Maciejak P, Bidziňski A, Skórzewska A, Turzyňska D, Plažnik A. 2006. Effects of methadone and morphine on c-Fos expression in the rat brain: similarities and differences. Pharmacol Rep 58:120-124.
59. Trigo JM, Martin-García E, Berrendero F, Robledo P, Maldonado R. 2010. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend 108:183-194.
60. Turchan J, Lason W, Budziszewska B, Przewlocka B. 1997. Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain. Neuropeptides 31:24-28.
61. Wang H, Moriwaki A, Wang JB, Uhl GR, Pickel VM. 1996. Ultrastructural immunocytochemical localization of mu opioid receptors and Leu5-enkephalin in the patch compartment of the rat caudate-putamen nucleus. J Comp Neurol 375:659-674.
62. Wang JQ, McGinty JF. 1997. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. J Pharmacol Exp Ther 281:972-982.
63. Werme M, Thorén P, Olson L, Brené S. 2000. Running and cocaine both upregulate dynorphin mRNA in medial caudate putamen. Eur J Neurosci 12:2967-2974.
64. Wise RA. 2009. Roles for nigrostriatal-not just mesocorticolimbic-dopamine in reward and addiction. Trends Neurosci 32:517-524.
65. Young WSD, Bonner TI, Brann MR. 1986. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci U S A 83:9827-9831.
66. Yukhananov RY, Handa RJ. 1997. Effect of morphine on proenkephalin gene expression in the rat brain. Brain Res Bull 43:349-356.
67. Zimprich A, Kraus J, Wöltje M, Mayer P, Rauch E, Höllt V. 2000. An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression. J Neurochem 74:472-477.
68. Ziólkowska B, Przewlocka B, Mika J, Labuz D, Przewlocki R. 1998. Evidence for Fos involvement in the regulation of proenkephalin and prodynorphin gene expression in the rat hippocampus. Brain Res Mol Brain Res 54:243-251.
69. Zurawski G, Benedik M, Kamb BJ, Abrams JS, Zurawski SM, Lee FD. 1986. Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 232:772-775.